Abstract
has been demonstrated in ischemia-reperfusion injury, nephrotoxin-induced renal injury, acute 74 glomerulonephritis, obstructive nephropathy and rhabdomyolysis (3, 7, 24, 25, 35, 37, 51, 53, 75 59, 62) . However, it should be noted that in vitro and ex vivo studies have demonstrated 76 deleterious effects of generalized HO-1 overexpression, which may be attributed to an increase 77 in iron release (9, 56, 67) . Furthermore, there have been several inconsistent reports on the 78 cytoprotective role of HO-1 following AKI. Prior upregulation of HO-1 or inhibition of HO activity 79 has resulted in contrasting outcomes, with worse, no apparent effect or reduction in severity of 80 AKI (2, 19, 22, 36, 66) . However, these studies utilized chemical modulators that have potential 81 non-specific effects, including immunostimulatory effects, altering the activity of NO synthase 82 and guanylate cyclase and altering the expression of adhesion molecules such as 83 29, 30, 40, 64) . Therefore, the use of such modulators has confounded the evaluation of the role 84 of HO-1 in injury. Recent studies using genetically deficient HO-1 mice, demonstrated a 85 protective role of HO-1 in several models of AKI, including, glycerol-induced rhabdomyolysis, 86 ischemia reperfusion injury and cisplatin-nephrotoxicity (38, 45, 53 
94
It is interesting to note that induction of HO-1 occurs in specific segments of the nephron 95 in different models of AKI, presumably in the proximity of the insult. While cisplatin maximally 96 accumulates and injures the S3 segment of the proximal tubule, rhabdomyolysis mainly 97 affects the S2 segment (8, 10, 50, 65) . Intriguingly, HO-1 is predominantly induced in 98 these segments following injury (3, 38) . In complex injury settings such as ischemia 99 reperfusion, HO-1 is induced in both the renal (e.g. tubular epithelium) and non-renal 100 compartments (inflammatory cells) (3, 12, 13, 61 
128
The ROSA-flox mice used to generate the HO-1 overexpressing mice were on a pure C57BL/6 129 background. The PEPCK cre mice were on a mixed background (embryonic stem cells from 130 129/Ola mice were injected into C57BL/6 blastocysts) and bred back on a C57BL/6 background 131 for more than 10 generations. The conditional HO-1 knockout flox mice were on a mixed 132 background (embryonic stem cells from 129/3 mice were injected into C57BL/6 blastocysts) and 133 bred back on a C57BL/6 background for more than 10 generations. Therefore, all the transgenic 134 mice used in this study were predominantly on a C57BL/6 background. Adult male mice (8 135 weeks of age) were provided acidified water (0.3M Ammonium chloride) for 1 week to enhance 136 PEPCK promoter activity in the kidney as previously described (68).
138

Quantification of mRNA Expression
139
Total RNA was isolated from tissues using TRIzol (Life Technologies), and SYBR Green-based 140 real-time PCR was performed on the cDNA product generated from total RNA (Qiagen, 
180
Lotus lectin staining to identify proximal tubules was performed as previously described 181 (68 (Fig. 1B) , human HO-1 was only expressed in the ROSA-
247
HO-1 kidneys (Fig. 1C) . We further verified this increase in HO-1 mRNA expression at the 248 protein level of ROSA-HO-1 kidneys compared to HO-1 +/+ mice (Fig. 1D ). In addition, there was 249 no difference in HO-1 protein expression in the heart, liver and spleen of ROSA-HO-1 mice 250 compared to HO-1 +/+ mice (Fig. 1D) 
254
Immunohistochemistry revealed that HO-1 was overexpressed specifically in the renal proximal 255 tubules, which was confirmed by colocalization with lotus lectin (Fig.1E ). administration was not different between the two transgenic mice groups ( Fig. 2A) , ROSA-HO-1 265 mice had significantly preserved kidney function, as measured by serum creatinine (Fig. 2B ).
266
Concurrently, ROSA-HO-1 mice had better preserved kidney architecture with fewer casts but 267 there was no difference in the number of necrotic tubules compared to HO-1 +/+ mice (Fig. 2C ).
268
We demonstrate that at the cellular level, ROSA-HO-1 kidneys expressed lower levels of 269 cleaved caspase 3 compared to cisplatin-treated HO-1 +/+ kidneys, indicating lower degree of 270 apoptosis in the presence of increased proximal tubule-specific HO-1 expression (Fig. 2D ).
271
Interestingly, while the expression of organic cation transporter 1 (OCT1) was not different,
272
OCT2 expression was significantly higher in the ROSA-HO-1 mice in the basal state (Fig 2E) .
273
However, following cisplatin administration, there was no difference in the expression of these 274 transporters between the two groups (Fig. 2E) . Analysis of kidney function and architecture at 5 275 days following cisplatin administration also revealed significant protection in the ROSA-HO-1 276 mice compared to HO-1 +/+ mice (Fig 2F-H) .
277
Generation and characterization of proximal tubule-specific HO-1 deletion mice
278
The floxed HO-1 (referred to as HO-1 +/+ ) mice were generated by flanking exons 3 and 4 with 279 lox p sites as previously described (60). Breeding of these floxed HO-1 mice with PEPCK cre 280 mice led to the generation of HO-1 PT-/-mice which do not express HO-1 only in the proximal 281 tubules of the kidney (Fig. 3A) . HO-1 expression was significantly lower only in the kidneys of 282 HO-1 PT-/-mice compared to HO-1 +/+ mice (Fig. 3B) 
348
Previous studies have generated transgenic mice that overexpress HO-1 in certain 349 organs using specific promoters to drive the expression of HO-1 cDNA. These promoters 350 include keratin (skin), alpha-myosin heavy chain (heart), glial fibrillary acidic protein (astrocyte)
351
and uromodulin (thick ascending limb) (6, 17, 55, 63 
